---
title: "Viridian Therapeutics (VRDN.US) — Financial Reports"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/VRDN.US/norm.md"
symbol: "VRDN.US"
name: "Viridian Therapeutics"
parent: "https://longbridge.com/en/quote/VRDN.US.md"
datetime: "2026-06-13T16:26:17.416Z"
locales:
  - [en](https://longbridge.com/en/quote/VRDN.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/VRDN.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/VRDN.US/norm.md)
---

# Viridian Therapeutics (VRDN.US) — Financial Reports

## Income Statement (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| EPS | -0.9004 | -1.07 | -0.3444 | -1.00 | -0.8690 |
| ROE | -67.29% | -89.42% | -35.19% | -88.40% | -62.95% |
| Revenue | 141000.00 | 132000.00 | 70.57M | 75000.00 | 72000.00 |
| Net income | -92.03M | -101.07M | -28.17M | -81.98M | -70.69M |
| Operating income | -116.17M | -126.25M | -40.01M | -106.77M | -93.87M |
| Gross margin | -50819.86% | -70133.33% | -22.23% | -115401.33% | -98631.94% |
| Net margin | -74397.87% | -91178.03% | -49.03% | -134313.33% | -120711.11% |
| Profit quality | - | - | - | - | - |

## Balance Sheet (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| A&L | 789.02M | 899.42M | 577.14M | 582.32M | 660.98M |
| Leverage | 1.24 | 1.25 | 1.15 | 1.13 | 1.09 |
| BVPS | 4.92 | 5.80 | 3.82 | 4.00 | 5.09 |
| Turnover | 0.0978 | 0.0863 | 0.1049 | 0.0005 | 0.0005 |
| Cash & STI | 762.18M | 874.65M | 490.90M | 563.36M | 636.63M |
| Inv & Rec | - | - | - | - | - |
| LT assets | 3.38M | 3.65M | 3.71M | 3.07M | 3.25M |
| Net debt | -708.83M | -822.06M | -466.70M | -540.27M | -613.53M |

## Cash Flow Statement (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | -119.65M | -23.75M | -84.61M | -75.37M | -92.65M |
| Investing CF | 77.26M | -339.42M | 126.08M | 75.72M | 100.06M |
| Financing CF | 6.36M | 405.91M | 10.86M | 764000.00 | 9.21M |
| Free CF | -80.98M | 13.87M | -72.52M | -40.20M | -62.31M |
| OCF coverage | -520234.78% | -9897.50% | -66622.83% | -179459.52% | -107736.05% |
| Repaid & issued | - | 28.88M | - | - | - |
| CapEx | -23000.00 | -240000.00 | -127000.00 | -42000.00 | -86000.00 |